mRNA-1273 COVID-19 vaccination in patients receiving chemotherapy, immunotherapy, or chemoimmunotherapy for solid tumours: a prospective, multicentre, non-inferiority trial
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
mRNA-1273 COVID-19 vaccination in patients receiving chemotherapy, immunotherapy, or chemoimmunotherapy for solid tumours: a prospective, multicentre, non-inferiority trial
Authors
Keywords
-
Journal
LANCET ONCOLOGY
Volume 22, Issue 12, Pages 1681-1691
Publisher
Elsevier BV
Online
2021-11-10
DOI
10.1016/s1470-2045(21)00574-x
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Duration and key determinants of infectious virus shedding in hospitalized patients with coronavirus disease-2019 (COVID-19)
- (2021) Jeroen J. A. van Kampen et al. Nature Communications
- The ESMO Call to Action on COVID-19 vaccinations and patients with cancer: Vaccinate. Monitor. Educate
- (2021) M.C. Garassino et al. ANNALS OF ONCOLOGY
- Persistence of antibodies to SARS-CoV-2 in relation to symptoms in a nationwide prospective study
- (2021) Gerco den Hartog et al. CLINICAL INFECTIOUS DISEASES
- COVID-19 vaccination: the VOICE for patients with cancer
- (2021) Astrid A. M. van der Veldt et al. NATURE MEDICINE
- Short-term safety of the BNT162b2 mRNA COVID-19 vaccine in patients with cancer treated with immune checkpoint inhibitors
- (2021) Barliz Waissengrin et al. LANCET ONCOLOGY
- Safety and immunogenicity of one versus two doses of the COVID-19 vaccine BNT162b2 for patients with cancer: interim analysis of a prospective observational study
- (2021) Leticia Monin et al. LANCET ONCOLOGY
- Neutralizing antibody levels are highly predictive of immune protection from symptomatic SARS-CoV-2 infection
- (2021) David S. Khoury et al. NATURE MEDICINE
- Antibody Persistence through 6 Months after the Second Dose of mRNA-1273 Vaccine for Covid-19
- (2021) Nicole Doria-Rose et al. NEW ENGLAND JOURNAL OF MEDICINE
- Immunogenicity of SARS-CoV-2 messenger RNA vaccines in patients with cancer
- (2021) Alfredo Addeo et al. CANCER CELL
- Seroconversion rates following COVID-19 vaccination among patients with cancer
- (2021) Astha Thakkar et al. CANCER CELL
- Immune responses to COVID-19 vaccines in patients with cancer: Promising results and a note of caution
- (2021) Elizabeth A. Griffiths et al. CANCER CELL
- COVID‐19 vaccine‐induced Stevens–Johnson syndrome
- (2021) S. Dash et al. CLINICAL AND EXPERIMENTAL DERMATOLOGY
- Reduced sensitivity of SARS-CoV-2 variant Delta to antibody neutralization
- (2021) Delphine Planas et al. NATURE
- A correlate of protection for SARS-CoV-2 vaccines is urgently needed
- (2021) Florian Krammer NATURE MEDICINE
- Infection and Vaccine-Induced Neutralizing-Antibody Responses to the SARS-CoV-2 B.1.617 Variants
- (2021) Venkata-Viswanadh Edara et al. NEW ENGLAND JOURNAL OF MEDICINE
- Bullous drug eruption after second dose of mRNA-1273 (Moderna) COVID-19 vaccine: Case report
- (2021) Joyce Kong et al. Journal of Infection and Public Health
- SARS-CoV-2 variants of concern partially escape humoral but not T-cell responses in COVID-19 convalescent donors and vaccinees
- (2021) Daryl Geers et al. Science Immunology
- Stevens-Johnson syndrome post second dose of Pfizer COVID-19 vaccine: a case report
- (2021) Mohamed Omar Elboraey et al. Oral Surgery Oral Medicine Oral Pathology Oral Radiology
- SARS-CoV-2-specific antibody detection for sero-epidemiology: a multiplex analysis approach accounting for accurate seroprevalence
- (2020) Gerco den Hartog et al. JOURNAL OF INFECTIOUS DISEASES
- Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine
- (2020) Lindsey R. Baden et al. NEW ENGLAND JOURNAL OF MEDICINE
- Priority COVID-19 Vaccination for Patients with Cancer while Vaccine Supply Is Limited
- (2020) Antoni Ribas et al. Cancer Discovery
- Inflammatory eruptions associated with immune checkpoint inhibitor therapy: A single-institutional, retrospective analysis with stratification of reactions by toxicity and implications for management
- (2018) Emily Coleman et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Comprehensive longitudinal analysis of hepatitis C virus (HCV)-specific T cell responses during acute HCV infection in the presence of existing HIV-1 infection
- (2009) C. H. S. B. van den Berg et al. JOURNAL OF VIRAL HEPATITIS
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now